3/26/2025Bayer Secures Global Rights to Puhe BioPharma's Experimental Cancer Dr...

3/26/2025NMPA Issues Announcement on the Implementation of Chinese Pharmacopoei...

3/26/2025NMPA Holds 2025 National Drug Regulatory Policy and Law Conference

3/26/2025Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...

3/26/2025Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346

3/25/2025Hengrui and Elevar Face Second FDA Rejection for Liver Cancer Combo Th...

3/25/2025Growing Awareness and Expanding Treatment Options for Sleep Disorders ...

3/25/2025Expedition Therapeutics Secures Seed Funding to Bridge Chinese Innovat...

3/25/2025China's BMI Fund Surpasses CNY16.5 Trillion with 11% Annual Growth

3/25/2025Merck Group to Expand in China with Focus on AI-Powered Precision Medi...

3/25/2025Eli Lilly Launches Lilly Gateway Laboratory in Beijing to Foster Innov...

3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...

3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...

3/25/2025Novo Nordisk and the United Labs Announce License Deal for UBT251

3/25/2025Anda Biopharma Secures Series A Funding to Advance PCNAT-01 Clinical S...

3/24/2025Heng Ren Partners Calls for $8.9B Cash Distribution from Sinovac and ... (Free)

3/24/2025China Sets Ambitious Nutritional Targets for 2030 to Improve National ...

3/24/2025CDE Seeks Public Comments on Draft ICH M11 Clinical Protocol Template

3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...

3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...

3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...

3/24/2025Syneron Bio Announces Strategic Collaboration with AstraZeneca

3/24/2025AstraZeneca Announces $2.5B Investment in China

3/24/2025HBM Enters into Global Strategic Deal with AstraZeneca for Next-Gen Th...

3/24/2025Elevation Oncology to Discontinue Development of CSPC-licensed EO-3021

3/21/2025Visen Pharma Debuts on Hong Kong Stock Exchange

3/21/2025Recent Executive Moves

3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China

3/21/2025Junshi's Toripalimab Receives 11th Approval in China

3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials

Page:4/47 Total number of articles:1391: [First][<<] [2] [3] [4] [5] [6] [>>] [End]